Trending...
- RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation
- Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community
- UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
Abzena Holdings (US) LLC, a life sciences contract development and manufacturing organization (CDMO), will locate a significant biopharmaceutical manufacturing site in Lee County, creating 325 jobs and investing $213 million in Sanford, Governor Roy Cooper announced today.
"Abzena recognized North Carolina as a leader in biotechnology and knew this was the right place to develop and manufacture new medicines and grow their business," said Governor Cooper.
Abzena, with headquarters in San Diego, California and sites in Bristol, Pennsylvania and Cambridge, United Kingdom offers its customers solutions in integrated early discovery to mid-phase pharmaceutical production. Working with companies and academic groups from around the world, including many of the top biopharmaceutical brands, Abzena supports the development and manufacture of better treatments for patients. The company's project in Lee County will establish a state-of-the-art manufacturing facility featuring a design optimized for phase 3 and commercial manufacturing of biologics. Using a phased construction approach, the company will initially build four modular production suites, with each of those suites capable of housing two large bioreactors.
"We are very appreciative for the entire team representing North Carolina for their partnership and the office of U.S. Senator Thom Tillis during the decision process" said Jonathan Goldman MD, CEO of Abzena. "We are delighted to support our customers and the patients they serve with this investment in North Carolina. This builds on the successful launch of our second cGMP biologics facility in San Diego in 2020. We are pleased to provide high quality integrated drug development services covering research as well as the clinical and commercial phases without the need for technology transfer.
More on ncarol.com
"Innovative companies set a high bar for excellence, and with today's decision, North Carolina once again meets and exceeds those standards," said North Carolina Commerce Secretary Machelle Baker Sanders. "We welcome Abzena to the state's growing life science industry cluster. As a former executive in this industry myself, it's great to see how North Carolina is leading the way in the product lifecycle for new medicines that will improve and save lives."
Although specific wages will vary depending on job role, the aggregate average salary of the new positions will reach $63,308, bringing $19.1 million of positive payroll impact into the regional economy each year. The current average wage in Lee County stands at $42,516.
Abzena's project in North Carolina, which will be formally carried out by a new, wholly owned subsidiary company, will be facilitated by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by $1.5 billion. Using a formula that takes into account the new tax revenues generated by the new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $6,940,800, spread over 12 years. Over those 12 years, new state tax revenues generated by the new jobs will exceed $45 million.
State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.
More on ncarol.com
Abzena's JDIG agreement could also move as much as $771,200 into a fund that helps rural communities across the state attract business in the future. When companies select a site located in a Tier 2 county such as Lee, their JDIG agreements move some of the new tax revenue into the state's Industrial Development Fund – Utility Account. Local communities in more economically challenged areas of the state use grants from the Utility Account to build public infrastructure projects, which can improve a community's ability to attract companies to their regions.
"We welcome these new biomanufacturing jobs to Lee County," said N.C. Representative John Sauls. "Our region is a vital part of North Carolina's growing life science industry cluster, and we're excited to see the many opportunities that Abzena will bring to our community."
"Many economic development partners worked together to bring this investment to Lee County," said N.C. Senator Jim Burgin. "These community partners will continue to collaborate with Abzena to help the company succeed now and for many years to come."
Partnering with the North Carolina Department of Commerce and the Economic Development Partnership of N.C. on this project were the North Carolina General Assembly, the North Carolina Community College System, the North Carolina Biotechnology Center, the Office of Senator Thom Tillis, Duke Energy, the City of Sanford, Lee County, and the Sanford Area Growth Alliance.
"Abzena recognized North Carolina as a leader in biotechnology and knew this was the right place to develop and manufacture new medicines and grow their business," said Governor Cooper.
Abzena, with headquarters in San Diego, California and sites in Bristol, Pennsylvania and Cambridge, United Kingdom offers its customers solutions in integrated early discovery to mid-phase pharmaceutical production. Working with companies and academic groups from around the world, including many of the top biopharmaceutical brands, Abzena supports the development and manufacture of better treatments for patients. The company's project in Lee County will establish a state-of-the-art manufacturing facility featuring a design optimized for phase 3 and commercial manufacturing of biologics. Using a phased construction approach, the company will initially build four modular production suites, with each of those suites capable of housing two large bioreactors.
"We are very appreciative for the entire team representing North Carolina for their partnership and the office of U.S. Senator Thom Tillis during the decision process" said Jonathan Goldman MD, CEO of Abzena. "We are delighted to support our customers and the patients they serve with this investment in North Carolina. This builds on the successful launch of our second cGMP biologics facility in San Diego in 2020. We are pleased to provide high quality integrated drug development services covering research as well as the clinical and commercial phases without the need for technology transfer.
More on ncarol.com
- New Research Finds a Good Deal Is All It Takes to Get Americans Booking a Last-Minute Vacation — and Most Already Have One on Their Mind
- GitKraken Introduces GitLens 19, Bringing Human and AI Workflows Together in One Workbench
- LĪNA Universal Balm Nominated for "Best Clean Skincare Product" at CertClean Beauty Awards
- Bronze Stevie Award Recognizes Satyadhar Joshi for AI Research and Public Policy Engagement
- Plumber Pros of Clayton NC Opens as Johnston County's #1-Rated Plumbing Choice
"Innovative companies set a high bar for excellence, and with today's decision, North Carolina once again meets and exceeds those standards," said North Carolina Commerce Secretary Machelle Baker Sanders. "We welcome Abzena to the state's growing life science industry cluster. As a former executive in this industry myself, it's great to see how North Carolina is leading the way in the product lifecycle for new medicines that will improve and save lives."
Although specific wages will vary depending on job role, the aggregate average salary of the new positions will reach $63,308, bringing $19.1 million of positive payroll impact into the regional economy each year. The current average wage in Lee County stands at $42,516.
Abzena's project in North Carolina, which will be formally carried out by a new, wholly owned subsidiary company, will be facilitated by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by $1.5 billion. Using a formula that takes into account the new tax revenues generated by the new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $6,940,800, spread over 12 years. Over those 12 years, new state tax revenues generated by the new jobs will exceed $45 million.
State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.
More on ncarol.com
- synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool
- Leading PDR Training Courses in Canada: Learn Paintless Dent Repair with PDR Academy & Tint Academy
- Five Years of Scattering Joy: Gioia dell'Amore Cellars Celebrates Five Years of Wine, Love & a Drea
- Move in this Fall! New Released Quick Move-In Townhomes at Heritage at South Brunswick with Limited-Time Incentives
- Crossroads4Hope Marks 25 Years Ensuring No One Faces Cancer Alone At its Inspiring Hope Gala
Abzena's JDIG agreement could also move as much as $771,200 into a fund that helps rural communities across the state attract business in the future. When companies select a site located in a Tier 2 county such as Lee, their JDIG agreements move some of the new tax revenue into the state's Industrial Development Fund – Utility Account. Local communities in more economically challenged areas of the state use grants from the Utility Account to build public infrastructure projects, which can improve a community's ability to attract companies to their regions.
"We welcome these new biomanufacturing jobs to Lee County," said N.C. Representative John Sauls. "Our region is a vital part of North Carolina's growing life science industry cluster, and we're excited to see the many opportunities that Abzena will bring to our community."
"Many economic development partners worked together to bring this investment to Lee County," said N.C. Senator Jim Burgin. "These community partners will continue to collaborate with Abzena to help the company succeed now and for many years to come."
Partnering with the North Carolina Department of Commerce and the Economic Development Partnership of N.C. on this project were the North Carolina General Assembly, the North Carolina Community College System, the North Carolina Biotechnology Center, the Office of Senator Thom Tillis, Duke Energy, the City of Sanford, Lee County, and the Sanford Area Growth Alliance.
0 Comments
Latest on ncarol.com
- Michael Maertens Hired as Century Fasteners Corp. – Chief Financial Officer
- Beneath the Cloudline Explores Hope After Collapse in a New YA Science-Fantasy Novel
- Built to Last: Why BSI Is Among the Nation's Fastest-Growing Companies, and One of Its Best Places to Work
- Bent Danholm's The Architecture of Demand Reaches No. 2 in Amazon Real Estate Sales
- Contracting Resources Group Named to Inc. 5000 for the Ninth Time
- ImagineX Named to 2026 Inc. 5000 List of America's Fastest-Growing Private Companies
- ASSIST Software Becomes One of the First European Companies Certified to ISO/IEC 42001
- The World's No.1 Superstar® Enters the Occult with New Track and Cinematic Visual "Under Your Spell"
- PricZone Launches Online Shopping Platform Offering Electronics, Gaming, and More
- Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community
- Lineus Medical Elevates Leadership to Accelerate Growth After Breakthrough Clinical Results
- Gateway Center Arena Announces Duane Curry as General Manger
- New from Regal House Publishing, The Parliament of Mice, classic animal fables retold as satires
- XRPPower Expands Platform Security With Enhanced Brand Protection and Official Verification Standards
- Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
- RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation
- UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
- International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea
- The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
- FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)